Table 2. Changes in BCVA over time.

	Baseline	1 month	2 months	3 months	6 months
Bevacizumab	0.72±0.23	0.6±0.18	0.52±0.18	0.49±0.15	0.47±0.14
Ranibizumab	0.73±0.22	0.61±0.25	0.49±0.24	0.48±0.23	0.45±0.20
P	0.812	0.87	0.46	0.91	0.75

x±s